{
  "id": 96283,
  "title": "Blood test predicts immunotherapy benefit early among patients with advanced lung cancer",
  "url": "https://urgent.news/2026/08/03/blood-test-predicts-immunotherapy-benefit-early-among-patients-with",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-03T17:00:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-blood-immunotherapy-benefit-early-patients.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy. This finding has the potential to facilitate early treatment decisions,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "ScienceDaily Health",
        "title": "Blood cancer’s genetic warning signs may appear years early",
        "url": "https://urgent.news/2026/08/01/blood-cancers-genetic-warning-signs-may-appear-years-early",
        "published": "2026-08-01T02:53:42.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}